Evidence map›Paper›PMID 34463481›Full record

ArticleJournal of the American Chemical Society2021

Reactivity of (bi-Oxazoline)organonickel Complexes and Revision of a Catalytic Mechanism.

Luchuan Ju, Qiao Lin, Nicole J LiBretto, Clifton L Wagner, Chunhua Tony Hu, Jeffrey T Miller, Tianning Diao

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Selective Ni(I)/Ni(III) Process for Consecutive Geminal C(spJournal of the American Chemical Society · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Ni-Catalyzed Asymmetric Reductive Arylation of α-Substituted Imides.Journal of the American Chemical Society · 2024
    Article
  9. Mechanism of Ni-Catalyzed Photochemical Halogen Atom-Mediated C(spJournal of the American Chemical Society · 2024
    Article
  10. Enantioselective C(spAccounts of chemical research · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Luchuan JuDepartment of Chemistry, New York University, 100 Washington Square East, New York, New York 10003, United States.
Qiao LinDepartment of Chemistry, New York University, 100 Washington Square East, New York, New York 10003, United States.
Nicole J LiBrettoDepartment of Chemical Engineering, Purdue University, 480 Stadium Mall Drive, West Lafayette, Indiana 47906, United States.
Clifton L WagnerDepartment of Chemistry, New York University, 100 Washington Square East, New York, New York 10003, United States.
Chunhua Tony HuDepartment of Chemistry, New York University, 100 Washington Square East, New York, New York 10003, United States.ORCID 0000-0002-8172-2202
Jeffrey T MillerDepartment of Chemical Engineering, Purdue University, 480 Stadium Mall Drive, West Lafayette, Indiana 47906, United States.ORCID 0000-0002-6269-0620
Tianning DiaoDepartment of Chemistry, New York University, 100 Washington Square East, New York, New York 10003, United States.ORCID 0000-0003-3916-8372

Funding

Stereoselective Alkene Carbofunctionalization: Method Development and MechanismR01GM127778 · NIGMS · NEW YORK UNIVERSITY · PI Tianning Diao · 2019 to 2026
$3.1M
NIGMS NIH HHS R01 GM127778
6 · The paper itself

Abstract

Bi-Oxazoline (biOx) has emerged as an effective ligand framework for promoting nickel-catalyzed cross-coupling, cross-electrophile coupling, and photoredox-nickel dual catalytic reactions. This report fills the knowledge gap of the organometallic reactivity of (biOx)Ni complexes, including catalyst reduction, oxidative electrophile activation, radical capture, and reductive elimination. The biOx ligand displays no redox activity in (biOx)Ni(I) complexes, in contrast to other chelating imine and oxazoline ligands. The lack of ligand redox activity results in more negative reduction potentials of (biOx)Ni(II) complexes and accounts for the inability of zinc and manganese to reduce (biOx)Ni(II) species. On the basis of these results, we revise the formerly proposed "sequential reduction" mechanism of a (biOx)Ni-catalyzed cross-electrophile coupling reaction by excluding catalyst reduction steps.

Identifiers

PMID34463481
PMCPMC8883516

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.